Page Options
Zhongshan VC-backed firm inks strategic deal with MSD
2025-11-18
During the recent 2025 MSD R&D China Science Day event, Usynova Pharmaceuticals Ltd signed a cooperation agreement with MSD R&D China.
This collaboration targets co-development of small-molecule therapies for autoimmune diseases, aiming to deliver more effective and accessible treatments for conditions like psoriasis and rheumatoid arthritis.
Usynova is invested by Zhongshan Venture Capital (Zhongshan VC), a subsidiary of Zhongshan Investment Holdings. Its partnership with the global pharma leader validates the company's innovative R&D prowess.
The deal underscores Zhongshan VC's strategic focus on biopharma, having backed cutting-edge firms like Tennor Therapeutics, Mabgeek Biotech, Zephyrm, Sinotau, Leman Biotech and Cingular Biotech in recent years.
ICP?Registration?Number:?粵ICP備?11005604號
Police?Registration?Number:?44200002442868
Website?ID:?4420000052
Sponsored?by:??Office?of?Zhongshan?Municipal?People's?Government
Technical?Support:???Information?Center?of?Zhongshan
Without?written?authorization?from??Zhongshan?Municipal?People’s?Government,?the?content?of?the?site?shall?not?be?republished?or?used?in?any?form.
About Us | Site Map| Privacy Statement| Contact us
久久毛片免费看一区二区三区_国产精品久久久久不卡绿巨人_亚洲欧美人成综合导航_国产亚洲男人的天堂在线观看
Police?Registration?Number:?44200002442868
Website?ID:?4420000052
Sponsored?by:??Office?of?Zhongshan?Municipal?People's?Government
Technical?Support:???Information?Center?of?Zhongshan
Without?written?authorization?from??Zhongshan?Municipal?People’s?Government,?the?content?of?the?site?shall?not?be?republished?or?used?in?any?form.
About Us | Site Map| Privacy Statement| Contact us